Trial intelligence / Profile preview

Ramelteon for Prevention of Postoperative Delirium in High-risk Older Cancer Patients (RAMP)

jRCTs031210673Active, not recruiting

Sponsor
Japan Agency for Medical Research and Development
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in delirium comparing Ramelteon arm with Placebo arm (2 arms). Started Apr 2022; status: active, not recruiting.

02

Drugs

ramelteon
03

Conditions

delirium

Beyond the preview

Go deeper on jRCTs031210673.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031210673.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call